The production and use of antibiotics increased significantly after the Second World War due to their effectiveness against bacterial infections. However, bacterial resistance also emerged and has now become an important global issue. Those most in need are typically high-risk and include individuals who experience burns and other wounds, as well as those with pulmonary infections caused by antibiotic-resistant bacteria, such as , and . With investment to develop new antibiotics waning, finding and developing alternative therapeutic strategies to tackle this issue is imperative. One option remerging in popularity is bacteriophage (phage) therapy. This review focuses on and how it has developed resistance to antibiotics. It also discusses the potential of phage therapy in this setting and its appropriateness in high-risk people, such as those with cystic fibrosis, where it typically forms a biofilm.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952150PMC
http://dx.doi.org/10.3390/antibiotics12020286DOI Listing

Publication Analysis

Top Keywords

phage therapy
12
therapy alternative
4
alternative treatment
4
treatment modality
4
modality resistant
4
resistant infections
4
infections production
4
production antibiotics
4
antibiotics increased
4
increased second
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!